Anti-EMC7 monoclonal antibody

Pre-made anti-EMC7 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to EMC7/EMC7 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0757-Ab-1/ GM-Tg-hg-IP0757-Ab-2Anti-Human EMC7 monoclonal antibodyHuman
GM-Tg-rg-IP0757-Ab-1/ GM-Tg-rg-IP0757-Ab-2Anti-Rat EMC7 monoclonal antibodyRat
GM-Tg-mg-IP0757-Ab-1/ GM-Tg-mg-IP0757-Ab-2Anti-Mouse EMC7 monoclonal antibodyMouse
GM-Tg-cynog-IP0757-Ab-1/ GM-Tg-cynog-IP0757-Ab-2Anti-Cynomolgus/ Rhesus macaque EMC7 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0757-Ab-1/ GM-Tg-felg-IP0757-Ab-2Anti-Feline EMC7 monoclonal antibodyFeline
GM-Tg-cang-IP0757-Ab-1/ GM-Tg-cang-IP0757-Ab-2Anti-Canine EMC7 monoclonal antibodyCanine
GM-Tg-bovg-IP0757-Ab-1/ GM-Tg-bovg-IP0757-Ab-2Anti-Bovine EMC7 monoclonal antibodyBovine
GM-Tg-equg-IP0757-Ab-1/ GM-Tg-equg-IP0757-Ab-2Anti-Equine EMC7 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0757-Ab-1/ GM-Tg-hg-IP0757-Ab-2; GM-Tg-rg-IP0757-Ab-1/ GM-Tg-rg-IP0757-Ab-2;
GM-Tg-mg-IP0757-Ab-1/ GM-Tg-mg-IP0757-Ab-2; GM-Tg-cynog-IP0757-Ab-1/ GM-Tg-cynog-IP0757-Ab-2;
GM-Tg-felg-IP0757-Ab-1/ GM-Tg-felg-IP0757-Ab-2; GM-Tg-cang-IP0757-Ab-1/ GM-Tg-cang-IP0757-Ab-2;
GM-Tg-bovg-IP0757-Ab-1/ GM-Tg-bovg-IP0757-Ab-2; GM-Tg-equg-IP0757-Ab-1/ GM-Tg-equg-IP0757-Ab-2
Products NameAnti-EMC7 monoclonal antibody
Formatmab
Target NameEMC7
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-EMC7 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0757-Ag-1Recombinant multi-species EMC7/ C11orf3/ C15orf24 protein
    ORF Viral VectorpGMLPm003239mouse Emc7 Lentivirus plasmid
    ORF Viral VectorvGMLPm003239mouse Emc7 Lentivirus particle


    Target information

    Target IDGM-IP0757
    Target NameEMC7
    Gene ID56851,73024,296050,695440,478242,101097489,615423,100057906
    Gene Symbol and Synonyms2900064A13Rik,C10H15orf24,C11orf3,C15orf24,C30H15orf24,EMC7,HT022,ORF1-FL1,ORF3,RGD1305045
    Uniprot AccessionQ9NPA0,A5PJA8
    Uniprot Entry NameEMC7_HUMAN,EMC7_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000134153
    Target ClassificationN/A

    The target: EMC7, gene name: EMC7, also named as C11orf3, C15orf24, HT022, ORF1-FL1. Contributes to membrane insertase activity. Involved in protein insertion into ER membrane by stop-transfer membrane-anchor sequence and tail-anchored membrane protein insertion into ER membrane. Is integral component of endoplasmic reticulum membrane. Part of EMC complex. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.